Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
InnoCan Pharma (INNPF)
OTHER OTC:INNPF
Holding INNPF?
Track your performance easily
INNPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.09 - $0.30
Previous Close$0.18
Volume100.00
Average Volume (3M)4.66K
Market Cap
$44.77M
Enterprise Value$40.78M
Total Cash (Recent Filing)$4.59M
Total Debt (Recent Filing)$7.00K
Price to Earnings (P/E)―
Beta0.36
Next Earnings
Nov 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding280,661,437
10 Day Avg. Volume10
30 Day Avg. Volume4,655
Standard Deviation0.28
R-Squared0.00218
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)10.55
Price to Sales (P/S)2.42
Price to Cash Flow (P/CF)-15.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.16
Enterprise Value/Gross Profit3.40
Enterprise Value/Ebitda-12.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
InnoCan Pharma News
PremiumCompany Announcements
Innocan Pharma Highlights FDA Milestones and New Website
PremiumCompany Announcements
Innocan Pharma’s LPT-CBD Eases Dog Arthritis Pain
PremiumCompany Announcements
InnoCan Pharma’s Advisor Among Top Cited Scientists
PremiumCompany Announcements
Innocan Pharma’s LPT-CBD Nears FDA Approval
PremiumCompany Announcements
InnoCan Pharma Subsidiary Triumphs with FDA and Announces Private Placement
PremiumCompany Announcements
InnoCan Pharma Soars with Strong Q2 2024 Financials
PremiumCompany Announcements
InnoCan Pharma Advances Veterinary CBD Drug with FDA NodPremiumCompany Announcements
InnoCan Pharma Hires Expert for FDA Approval BidOptions Prices
Currently, No data available
---
Ownership Overview
INNPF FAQ
What was InnoCan Pharma’s price range in the past 12 months?
InnoCan Pharma lowest stock price was $0.09 and its highest was $0.30 in the past 12 months.
What is InnoCan Pharma’s market cap?
Currently, no data Available
When is InnoCan Pharma’s upcoming earnings report date?
InnoCan Pharma’s upcoming earnings report date is Nov 27, 2024 which is in 39 days.
How were InnoCan Pharma’s earnings last quarter?
InnoCan Pharma released its earnings results on Aug 12, 2024. The company reported $0.001 earnings per share for the quarter, beating the consensus estimate of N/A by $0.001.
Is InnoCan Pharma overvalued?
According to Wall Street analysts InnoCan Pharma’s price is currently Overvalued.
Does InnoCan Pharma pay dividends?
InnoCan Pharma does not currently pay dividends.
What is InnoCan Pharma’s EPS estimate?
InnoCan Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InnoCan Pharma have?
InnoCan Pharma has 280,661,440 shares outstanding.
What happened to InnoCan Pharma’s price movement after its last earnings report?
InnoCan Pharma reported an EPS of $0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 11.765%.
Which hedge fund is a major shareholder of InnoCan Pharma?
Currently, no hedge funds are holding shares in INNPF
---
InnoCan Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Sold Shares
Worth $12.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.55%
12-Months-Change
Fundamentals
Return on Equity
-88.27%
Trailing 12-Months
Asset Growth
47.68%
Trailing 12-Months
Company Description
InnoCan Pharma
InnoCan Pharma Corp is a Canada based company engaged in the research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products. Its brands include Shir and Relief & Go.
---
Technical Analysis
---